PHARMACOKINETICS (PK) OF SACITUZUMAB GOVITECAN (SG), A TROP-2-DIRECTED ANTIBODY-TOPOISOMERASE I INHIBITOR SN-38 DRUG-CONJUGATE, IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要